EFFECTS OF ELUXADOLINE TREATMENT ON ABDOMINAL AND BOWEL SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHEA REPORTING INADEQUATE SYMPTOM CONTROL WITH LOPERAMIDE: AGGREGATED RESULTS FROM PHASE 3 AND 4 CLINICAL TRIALS

Darren M Brenner  1     Gregory Sayuk  2     Mazen Saeed  3     Peter Janiszewski  4     Louis Liu  5    
1 Northwestern University,Chicago,United States
2 Washington University School of Medicine,St. Louis,United States
3 AbbVie Inc,Madison,United States
4 AbbVie Inc,Toronto,Canada
5 University Health Network,Toronto,Canada

Session
IBS I

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing